Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than One

J Thorac Oncol. 2022 Feb;17(2):176-178. doi: 10.1016/j.jtho.2021.11.004.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Apoptosis Regulatory Proteins / therapeutic use
  • B7-H1 Antigen / therapeutic use
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / metabolism
  • Humans
  • Immune Checkpoint Inhibitors
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / metabolism

Substances

  • Apoptosis Regulatory Proteins
  • B7-H1 Antigen
  • Immune Checkpoint Inhibitors